Carl L. G. Hansen
Chief Executive Officer at AbCellera Biologics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AbCellera Biologics Inc., 3 years.
AbCellera Biologics Inc.
Director · Chief Executive Officer
Chief executive roles
AbCellera Biologics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2024 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| Sep 20, 2024 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| May 31, 2024 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| Feb 26, 2024 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| Nov 23, 2023 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| Aug 24, 2023 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| May 26, 2023 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
| Feb 22, 2023 | AbCellera Biologics Inc. | Option exercise | +56,125 | $2.70 | $151,538 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.